Digoxin use is associated with pancreatic cancer risk but does not affect survival.
Saved in:
| Title: | Digoxin use is associated with pancreatic cancer risk but does not affect survival. |
|---|---|
| Authors: | Boursi B; Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Tel-Aviv University, Tel-Aviv, Israel. ben.boursi@sheba.health.gov.il.; Department of Oncology, Sheba Medical Center, Tel-Hashomer, Israel. ben.boursi@sheba.health.gov.il., Huber JS; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Haynes K; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Mamtani R; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Yang YX; Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. |
| Source: | Cancer causes & control : CCC [Cancer Causes Control] 2021 Jan; Vol. 32 (1), pp. 41-46. Date of Electronic Publication: 2020 Oct 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9100846 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7225 (Electronic) Linking ISSN: 09575243 NLM ISO Abbreviation: Cancer Causes Control Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33064241 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Digoxin use is associated with pancreatic cancer risk but does not affect survival. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Boursi+B%22">Boursi B</searchLink>; Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Tel-Aviv University, Tel-Aviv, Israel. ben.boursi@sheba.health.gov.il.; Department of Oncology, Sheba Medical Center, Tel-Hashomer, Israel. ben.boursi@sheba.health.gov.il.<br /><searchLink fieldCode="AU" term="%22Huber+JS%22">Huber JS</searchLink>; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Haynes+K%22">Haynes K</searchLink>; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mamtani+R%22">Mamtani R</searchLink>; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Yang+YX%22">Yang YX</searchLink>; Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229100846%22">Cancer causes & control : CCC</searchLink> [Cancer Causes Control] 2021 Jan; Vol. 32 (1), pp. 41-46. <i>Date of Electronic Publication: </i>2020 Oct 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic+Publishers%22">Kluwer Academic Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9100846 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7225 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209575243%22">09575243 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Causes Control <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33064241 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10552-020-01352-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 41 Titles: – TitleFull: Digoxin use is associated with pancreatic cancer risk but does not affect survival. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Boursi B – PersonEntity: Name: NameFull: Huber JS – PersonEntity: Name: NameFull: Haynes K – PersonEntity: Name: NameFull: Mamtani R – PersonEntity: Name: NameFull: Yang YX IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2021 Jan Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1573-7225 Numbering: – Type: volume Value: 32 – Type: issue Value: 1 Titles: – TitleFull: Cancer causes & control : CCC Type: main |
| ResultId | 1 |